iscalimab

Showing 1 posts of 1 posts found.

First-of-its-kind data shows Novartis’ iscalimab extends survival of transplanted kidneys

June 6, 2019
Research and Development Novartis, iscalimab, kidney transplant, pharma, transplant

In a first-of-its-kind reveal, Novartis has presented histology data for iscalimab (CFZ533) at the American Transplant Congress (ATC) which indicates …

Latest content